Supplements and Featured Publications
Navigating Critical Updates in Advanced Breast Cancer Management From ASCO 2026
Volume: 1
Issue: 1
Emerging Data Advancing Precision Medicine Across GI Malignancies From ASCO 2026
Volume: 1
Issue: 1
Assessing Recurrence Risk in Early-Stage Triple-Negative Breast Cancer
Volume: 1
Issue: 1
Treatment and Adherence Strategies in Cutaneous T-Cell Lymphoma
Volume: 1
Issue: 1
State of the Science Summit Recaps
Volume: 1
Issue: 1
Traversing Novel Allogeneic Cellular Therapy Strategies in Hematologic Oncology
Volume: 1
Issue: 1
TKI Selection and Sequencing Considerations in CML and ALL
Volume: 1
Issue: 1
2026 ASCO Genitourinary Cancers Symposium: Focus on Prostate Cancer
Volume: 1
Issue: 1
Exploring Alternate Allogeneic Immunotherapy Strategies in Hematologic Oncology
Volume: 1
Issue: 1
Practical Updates in Cutaneous Squamous Cell Carcinoma: From Disease Biology to Real-World Management
Volume: 1
Issue: 1
Exploring Immunotherapy Strategies in SCAC and MCC
Volume: 1
Issue: 1
Bridging Scientific Progress With Real-World Practice in SCLC Care
Volume: 1
Issue: 1
Personalizing Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
Volume: 1
Issue: 1
Evolving IO Management Strategies in Cutaneous Squamous Cell Carcinoma
Volume: 1
Issue: 1
Leveraging ctDNA/MRD Testing in Breast Cancer Management
Volume: 1
Issue: 1
Examining Second-Line Treatment Approaches in R/R Mantle Cell Lymphoma
Volume: 1
Issue: 1
Exploring the Role of FES-PET/CT in Breast Cancer Management
Volume: 1
Issue: 1
Exploring MRD Assessment in Lymphoma Management
Volume: 1
Issue: 1
Experts detail the exploration of minimal residual disease and the integration of ctDNA into lymphoma management.
The Evolving Role of Next-Generation Sequencing in NSCLC Management
Volume: 1
Issue: 1
Navigating Novel Allogeneic Immunotherapy Approaches in Hematologic Malignancies
Volume: 1
Issue: 1
Advancing Adjuvant Care: Exploring Oral SERDs in ER+, HER2-Negative Early Breast Cancer
Volume: 1
Issue: 1
Exploring Bispecific Approaches in Frontline Non-Hodgkin Lymphoma
Volume: 1
Issue: 1
Navigating TKI Selection in Leukemia Care
Volume: 1
Issue: 1
Traversing Key Updates in HR+ and Triple-Negative Breast Cancer
Volume: 1
Issue: 1
Exploring Novel Second- and Third-Line Approaches in Metastatic Colorectal Cancer
Volume: 1
Issue: 1
Managing LEMS in SCLC and Oncology Care
Volume: 1
Issue: 1
Navigating Second-Line Treatment in Pediatric Low-Grade Glioma
Volume: 1
Issue: 1
Experts discuss ongoing research and factors driving treatment selection in second-line pediatric low-grade glioma.
Exploring CELMoDs in Multiple Myeloma Management
Volume: 1
Issue: 1
Experts discuss ongoing research with CELMoDs in the treatment of patients with multiple myeloma.
Measuring the Effect of Experimental Approaches in Metastatic TNBC
Volume: 1
Issue: 1
Breast Cancer Awareness Month: Navigating the Incorporation of ADCs
Volume: 1
Issue: 1
Experts discuss the evolving role and ongoing research with antibody-drug conjugates in the management of breast cancer.
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5